Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
2006

Antimicrobial Resistance Patterns in Staphylococcus aureus in the US

Sample size: 3209413 publication Evidence: high

Author Information

Author(s): David Styers, Daniel J Sheehan, Patricia Hogan, Daniel F Sahm

Primary Institution: Focus Bio-Inova, Inc.

Hypothesis

What are the current antimicrobial resistance patterns and trends among Staphylococcus aureus in the United States?

Conclusion

The prevalence of MRSA among both inpatient and outpatient specimens continues to increase, with multi-drug resistance being a common phenotype.

Supporting Evidence

  • S. aureus was the most prevalent species isolated from inpatient specimens (18.7% of all bacterial isolates).
  • MRSA rates were 59.2% for non-ICU inpatients, 55% for ICU patients, and 47.9% for outpatients.
  • Multi-drug resistance phenotypes were common among both inpatient (59.9%) and outpatient (40.8%) MRSA.

Takeaway

This study looked at how many Staphylococcus aureus bacteria are resistant to antibiotics in the US, and found that more and more of them are resistant, especially in hospitals and clinics.

Methodology

Data from The Surveillance Network-USA, which collects microbiology data from 300 clinical laboratories across the US, was analyzed for prevalence and resistance trends.

Potential Biases

The study may be biased due to the higher likelihood of reporting S. aureus regardless of the amount of organisms present.

Limitations

The reporting frequency based on laboratory data may be higher than the actual frequency of infections caused by S. aureus.

Participant Demographics

Data was collected from geographically and demographically diverse patient populations across the United States.

Digital Object Identifier (DOI)

10.1186/1476-0711-5-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication